Complete results of the first randomized, placebo-controlled study of bosentan, a dual endothelin receptor antagonist, in pulmonary arterial hypertension
暂无分享,去创建一个
D. Badesch | A. Frost | G. Simonneau | O. Sitbon | V. Tapson | M. Rainisio | L. Rubin | S. Roux | R. Channick | I. Robbins | F. Bodin